23-24 February 2010
London, UK

Breakthrough innovations such as patients in Phase I trials, earlier proof of concept, umbrella protocols, challenging agents and adaptive design are just some of the ways in which industry is moving forward…..

Are you fully up to date with these new concepts?  

Attend Informa’s 11th Annual Phase I Clinical Trials conference to make sure that you are!

This is the only early stage clinical development event to offer the most up to date innovations from top industry experts, including:

Tony Johnson, Vice President, Bristol-Myers Squibb, Thomas Senderovitz, Vice President, UCB Pharma, and Paul de Koning, Vice President, Astellas Pharma.

What’s more, you will discover that our conference features the latest regulatory updates from top European regulators including the MHRA UK, FAMHP Belgium and AGES Austria.

Furthermore, you will see that your inspirational speaker for 2010 is Vivienne Parry science writer and BBC broadcaster, member of the Duff Enquiry investigating TGN 1412 and a former member of the Clinical Trials Expert Advisory Group of the MHRA.  Vivienne will provide a unique and entertaining insight into early stage clinical trials.

This is the only early stage development conference to offer:

• 12 keynote sessions from an unrivalled quality of Vice Presidents, Directors/Heads of Early Clinical Development and European regulators
• 6 first rate streams so that you may tailor your time and get the most value out of the event
• 5 exceptional pre-and post-conference interactive sessions to enhance your experience at the event

“A good mixture of presentations, and good speakers to keep our attention”, Eli Lilly 2009

Take a look at our website to find out more: www.informa-ls.com/phase1 or email registrations@informa-ls.com